Target intelligence / Profile preview

Parallel G-quadruplex DNA (G4 DNA) (G4 DNA)

Target
G4 DNA
Molecular classification
Nucleic acid, Non-canonical DNA structure, Other
01

Overview

Parallel G-quadruplex DNA (G4 DNA) is a non-canonical nucleic acid structure formed by guanine-rich sequences where four strands align in a parallel orientation, stabilized by stacked G-tetrads and monovalent cations (Rhodes & Lipps, 2015, Nucleic Acids Research). These structures are predominantly located in critical genomic regions, including the promoters of oncogenes like c-MYC and KRAS, as well as at telomeric ends (Huppert & Balasubramanian, 2007, Nucleic Acids Research). Biologically, parallel G4s serve as regulatory elements that modulate gene transcription, DNA replication, and telomere protection by acting as physical barriers or recruitment sites for proteins. In disease states, particularly cancer, the formation and stability of these structures are often dysregulated, contributing to the overexpression of growth-promoting genes. Therapeutic strategies involve using small-molecule ligands to stabilize parallel G4s, which can selectively repress oncogene expression or disrupt telomere maintenance, leading to cell cycle arrest and apoptosis in malignant cells (Balasubramanian et al., 2011, Nature Reviews Drug Discovery). Consequently, parallel G-quadruplex DNA represents a high-value target for precision oncology and the development of novel chemotherapeutic agents.

Other names
Parallel G4 DNAG-quadruplex DNAG4-DNAG-tetraplex DNA
02

Mechanism of action

Small-molecule ligands bind to and stabilize the G-tetrad stacks of the parallel G-quadruplex, which physically blocks the progression of RNA polymerase or DNA polymerase, inhibits telomerase access to telomeres, and triggers a DNA damage response (Balasubramanian et al., 2011, Nature Reviews Drug Discovery; Drygin et al., 2011, Cancer Research).

03

Biological functions

Transcription regulationTelomere maintenanceDNA replicationCell cycleOther
04

Disease associations

CancerNeurodegenerative diseaseInfectionOther
05

Safety considerations

Off-target effects on non-oncogenic G4-containing genesPotential for widespread genomic instabilityToxicity in rapidly dividing healthy cellsPoor bioavailability of large G4-binding ligands
06

Interacting drugs

Pidnarulex (CX-5461)

5 more in the full profile.

07

Biomarkers

BG4 antibody bindingc-MYC protein levelsTelomere lengthDNA damage markers (gamma-H2AX)

Beyond the preview

Go deeper on Parallel G-quadruplex DNA (G4 DNA) (G4 DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parallel G-quadruplex DNA (G4 DNA) (G4 DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call